318 related articles for article (PubMed ID: 33451855)
1. Dysregulation of Cell Signaling by SARS-CoV-2.
Suryawanshi RK; Koganti R; Agelidis A; Patil CD; Shukla D
Trends Microbiol; 2021 Mar; 29(3):224-237. PubMed ID: 33451855
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Nonstructural Protein 1 Inhibits the Interferon Response by Causing Depletion of Key Host Signaling Factors.
Kumar A; Ishida R; Strilets T; Cole J; Lopez-Orozco J; Fayad N; Felix-Lopez A; Elaish M; Evseev D; Magor KE; Mahal LK; Nagata LP; Evans DH; Hobman TC
J Virol; 2021 Jun; 95(13):e0026621. PubMed ID: 34110264
[TBL] [Abstract][Full Text] [Related]
3. Host proviral and antiviral factors for SARS-CoV-2.
Lv L; Zhang L
Virus Genes; 2021 Dec; 57(6):475-488. PubMed ID: 34510331
[TBL] [Abstract][Full Text] [Related]
4. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses.
Banerjee AK; Blanco MR; Bruce EA; Honson DD; Chen LM; Chow A; Bhat P; Ollikainen N; Quinodoz SA; Loney C; Thai J; Miller ZD; Lin AE; Schmidt MM; Stewart DG; Goldfarb D; De Lorenzo G; Rihn SJ; Voorhees RM; Botten JW; Majumdar D; Guttman M
Cell; 2020 Nov; 183(5):1325-1339.e21. PubMed ID: 33080218
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
7. Activation and evasion of type I interferon responses by SARS-CoV-2.
Lei X; Dong X; Ma R; Wang W; Xiao X; Tian Z; Wang C; Wang Y; Li L; Ren L; Guo F; Zhao Z; Zhou Z; Xiang Z; Wang J
Nat Commun; 2020 Jul; 11(1):3810. PubMed ID: 32733001
[TBL] [Abstract][Full Text] [Related]
8. Structure of Nonstructural Protein 1 from SARS-CoV-2.
Clark LK; Green TJ; Petit CM
J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
[TBL] [Abstract][Full Text] [Related]
9. Insight into the emerging role of SARS-CoV-2 nonstructural and accessory proteins in modulation of multiple mechanisms of host innate defense.
Abdalla AE; Xie J; Junaid K; Younas S; Elsaman T; Abosalif KOA; Alameen AAM; Mahjoob MO; Elamir MYM; Ejaz H
Bosn J Basic Med Sci; 2021 Oct; 21(5):515-527. PubMed ID: 33714258
[TBL] [Abstract][Full Text] [Related]
10. [Interaction between SARS-CoV-2 and Host Innate Immunity].
Duan XQ; Xie H; Chen LM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jan; 53(1):1-6. PubMed ID: 35048592
[TBL] [Abstract][Full Text] [Related]
11. Overview of SARS-CoV-2 genome-encoded proteins.
Bai C; Zhong Q; Gao GF
Sci China Life Sci; 2022 Feb; 65(2):280-294. PubMed ID: 34387838
[TBL] [Abstract][Full Text] [Related]
12. Sarbecovirus ORF6 proteins hamper induction of interferon signaling.
Kimura I; Konno Y; Uriu K; Hopfensperger K; Sauter D; Nakagawa S; Sato K
Cell Rep; 2021 Mar; 34(13):108916. PubMed ID: 33765414
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Signature of Host Response to SARS-CoV-2 Infection in the Nasopharynx.
Vanderboom PM; Mun DG; Madugundu AK; Mangalaparthi KK; Saraswat M; Garapati K; Chakraborty R; Ebihara H; Sun J; Pandey A
Mol Cell Proteomics; 2021; 20():100134. PubMed ID: 34400346
[TBL] [Abstract][Full Text] [Related]
14. METTL3 regulates viral m6A RNA modification and host cell innate immune responses during SARS-CoV-2 infection.
Li N; Hui H; Bray B; Gonzalez GM; Zeller M; Anderson KG; Knight R; Smith D; Wang Y; Carlin AF; Rana TM
Cell Rep; 2021 May; 35(6):109091. PubMed ID: 33961823
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
Finkel Y; Gluck A; Nachshon A; Winkler R; Fisher T; Rozman B; Mizrahi O; Lubelsky Y; Zuckerman B; Slobodin B; Yahalom-Ronen Y; Tamir H; Ulitsky I; Israely T; Paran N; Schwartz M; Stern-Ginossar N
Nature; 2021 Jun; 594(7862):240-245. PubMed ID: 33979833
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO.
Wu J; Shi Y; Pan X; Wu S; Hou R; Zhang Y; Zhong T; Tang H; Du W; Wang L; Wo J; Mu J; Qiu Y; Yang K; Zhang LK; Ye BC; Qi N
Cell Rep; 2021 Feb; 34(7):108761. PubMed ID: 33567255
[TBL] [Abstract][Full Text] [Related]
17. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
18. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Membrane (M) and Spike (S) Proteins Antagonize Host Type I Interferon Response.
Zhang Q; Chen Z; Huang C; Sun J; Xue M; Feng T; Pan W; Wang K; Dai J
Front Cell Infect Microbiol; 2021; 11():766922. PubMed ID: 34950606
[TBL] [Abstract][Full Text] [Related]
19. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block.
Burke JM; St Clair LA; Perera R; Parker R
RNA; 2021 Nov; 27(11):1318-1329. PubMed ID: 34315815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
